뒤로
Inhibikase Therapeutics Inc(IKT) 가격
IKT 주가 차트
IKT 수입
Inhibikase Therapeutics Inc
$1.67
1.82%
$0.03
종가: Feb 13, 16:00:00 GMT-5
$1.65
-1.19%
$-0.02
애프터마켓: Feb 13, 20:00:00 GMT-5
주요 통계
이전 종가
$1.64
시가
$1.64
일일 범위
$1.64 - $1.73
52주 범위
$1.33 - $3.32
거래량
218.2K
평균 거래량
449.4K
EPS(TTM)
-1.15
배당수익률
--
시가총액
$199.4M
IKT란 무엇인가요?
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 15 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).